News and Activities

SKR Reveals First Half 2024 Results with Total Revenue of 3,019.18 Million Baht The number of cases of difficult surgical treatment increased due to the development of medical capacity. Health check-up services through mobile hospitals and proactive check-up work for the government growth project, the board paid a dividend of 185 million baht. The company is expected to continue to grow in the third quarter of 2024, reiterating its strategy to develop a leading medical institution to become a Center of Excellence with the "24-hour Specialized Sikarin Service". Continuing to upgrade the level of the organization and growing sustainably, the company recently won a full 100 points in the AGM Checklist

Mr. Suriyan Kojaroj Executive Vice President and Chief Operating Officer Sikarin Public Company Limited or SKR disclosed its operating results for the first half of 2024 that the company had a total revenue of 3,019.18 million baht. An increase of 256.77 million baht or 9.30% from the same period last year and a net profit of 401.87 million baht. The Board of Directors approved the interim dividend payment of Baht 185 million in cash. The dividend will be paid on September 12, 2024 at the rate of Baht 0.09 per share

"Operating revenue in the first half of 2024 grew due to the increase in medical capacity. As a result, the number of general patients and social security patients who receive services for difficult diseases complicated by surgery continues to increase. In addition, there is also growth in health check-up services through mobile hospitals and proactive health check-ups in various government projects. The main reason for the decline in profit was that in the second quarter of 2024, the Social Security Office adjusted the rate of medical services. For the period of Statement 6611-6702 of 2023 from 12,000 baht/case to 7,200 baht/case, the revenue that has been adjusted has been recorded in the 2Q24 statement in full 100%, so there will be no continuous impact on the second half of 2024."

Mr. Suriyan added that the overall picture of 2024, the company will be able to generate growth according to the set target. Based on the strategy of increasing medical capacity through 6 leading medical institutions (Centers of Excellence), namely the Institute of Orthopedics, the Institute of Cardiology, the Institute of Pediatrics, the Institute of Women's Specialized Health, the Institute of Vascular and Neurological Systems, and the Institute of Gastroenterology and Hepatology. Launched the "Institute of Emergency Medicine" as an extension of the "24-hour Specialized Sikarin" Under the concept, we are more than an emergency center, with a team of emergency medicine doctors providing treatment for urgent or emergency illnesses, as well as specialized doctors to diagnose diseases. In addition, patients can access the diagnostic process through the Medical Laboratory Analysis Service Center and the Diagnostic Radiology Center in a timely manner. In addition, it is possible to treat difficult and complex diseases with immediate surgery. Under Thailand's leadership in the treatment of difficult and complex diseases with surgery

"Recently, the Company received the highest score of 100 points or Excellent level from the evaluation of the 2024 Annual General Meeting of Shareholders (AGM) Checklist by the Thai Investors Association and the Thai Capital Market Business Council. This reinforces the company's role model with quality communication between shareholders and management, which reflects business operations that are managed with good governance principles. There is a corporate governance approach that takes into account all stakeholders and is socially responsible. This is in line with the Company's goal of becoming a national organization with competitive potential and sustainable growth."

Source: กรุงเทพธุรกิจ